We are live on
!
Find out more
APC
Alpine Peaks Capital Portfolio holdings
AUM
$85.4M
1-Year Est. Return
11.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.49%
1 Year Est. Return
+11.24%
3 Year Est. Return
+24.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$111M
AUM Growth
-$10.9M
(-8.9%)
Cap. Flow
-$3.07M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
60.21%
Holding
25
New
2
Increased
9
Reduced
14
Closed
–
Avg Time Held
10.2
quarters
Top 10 Avg Time Held
6.1
quarters
Top 20 Avg Time Held
9.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$678K |
| 2 |
US Physical Therapy
USPH
|
+$671K |
| 3 |
Descartes Systems
DSGX
|
+$608K |
| 4 |
West Pharmaceutical
WST
|
+$413K |
| 5 |
Littelfuse
LFUS
|
+$343K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rollins
ROL
|
+$1.3M |
| 2 |
Interparfums
IPAR
|
+$1.13M |
| 3 |
Trimble
TRMB
|
+$985K |
| 4 |
Wabtec
WAB
|
+$892K |
| 5 |
Qualys
QLYS
|
+$663K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 32.16% |
| 2 | Technology | 27.07% |
| 3 | Consumer Discretionary | 19.54% |
| 4 | Healthcare | 16.79% |
| 5 | Consumer Staples | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bright Horizons
BFAM
$3.38B
| $8.95M | 8.07% |
70,451
-1,300
| -2% | -$160K |
2021 Q4
13 quarters
|
|
2
HEICO Corp Class A
HEI.A
$31.2B
| $8.56M | 7.72% |
40,569
+1,400
| +4% | +$271K |
2021 Q4
13 quarters
|
|
|
3
Rollins
ROL
$15.4B
| $7.72M | 6.96% |
142,868
-25,900
| -15% | -$1.3M |
2022 Q1
12 quarters
|
|
4
Medpace
MEDP
$17.1B
| $6.67M | 6.02% |
21,906
+800
| +4% | +$269K |
2021 Q4
13 quarters
|
|
5
Cognex
CGNX
$10.6B
| $6.18M | 5.57% |
207,219
+9,000
| +5% | +$317K |
2021 Q4
13 quarters
|
|
6
Evertec
EVTC
$1.77B
| $6.13M | 5.53% |
166,798
-5,500
| -3% | -$190K |
2021 Q4
13 quarters
|
|
|
7
US Physical Therapy
USPH
$1.26B
| $6.07M | 5.48% |
83,934
+8,000
| +11% | +$671K |
2021 Q4
13 quarters
|
|
|
8
Trimble
TRMB
$14B
| $5.8M | 5.23% |
88,283
-13,700
| -13% | -$985K |
2021 Q4
13 quarters
|
|
9
Jack Henry & Associates
JKHY
$10.5B
| $5.44M | 4.91% |
29,797
-700
| -2% | -$122K |
2023 Q1
8 quarters
|
|
10
Advanced Drainage Systems
WMS
$9.49B
| $5.25M | 4.73% |
48,320
+2,000
| +4% | +$233K |
2024 Q1
4 quarters
|
|
11
Service Corp International
SCI
$10.5B
| $5M | 4.51% |
62,332
-4,009
| -6% | -$315K |
2021 Q4
13 quarters
|
|
|
12
Interparfums
IPAR
$3.59B
| $4.93M | 4.44% |
43,259
-8,500
| -16% | -$1.13M |
2021 Q4
13 quarters
|
|
|
13
West Pharmaceutical
WST
$25.8B
| $4.75M | 4.29% |
21,233
+1,500
| +8% | +$413K |
2021 Q4
13 quarters
|
|
14
Barrett Business Services
BBSI
$769M
| $4.75M | 4.28% |
115,352
-11,500
| -9% | -$479K |
2021 Q4
13 quarters
|
|
|
15
Wabtec
WAB
$48.2B
| $4.19M | 3.77% |
23,080
-4,650
| -17% | -$892K |
2021 Q4
13 quarters
|
|
16
Trex
TREX
$4.56B
| $4.16M | 3.75% |
71,575
+2,700
| +4% | +$175K |
2022 Q4
9 quarters
|
|
17
Robert Half
RHI
$3.47B
| $3.73M | 3.36% |
68,336
-6,500
| -9% | -$396K |
2021 Q4
13 quarters
|
|
|
18
Littelfuse
LFUS
$10.8B
| $3.41M | 3.08% |
17,350
+1,500
| +9% | +$343K |
2024 Q2
3 quarters
|
|
|
19
Qualys
QLYS
$7B
| $2.51M | 2.26% |
19,905
-4,900
| -20% | -$663K |
2021 Q4
13 quarters
|
|
20
Resources Connection
RGP
$98.2M
| $1.91M | 1.72% |
292,201
-25,000
| -8% | -$194K |
2021 Q4
13 quarters
|
|
21
TriNet
TNET
$3B
| $1.83M | 1.65% |
23,150
-1,200
| -5% | -$99.6K |
2024 Q2
3 quarters
|
|
|
22
HEICO Corp
HEI
$41.7B
| $1.3M | 1.17% |
4,852
-1,150
| -19% | -$280K |
2021 Q4
13 quarters
|
|
|
23
Bio-Techne
TECH
$11.4B
| $586K | 0.53% |
+10,000
| New | +$678K |
2025 Q1
0 quarters
|
|
|
24
Descartes Systems
DSGX
$7.09B
| $555K | 0.5% |
+5,500
| New | +$608K |
2025 Q1
0 quarters
|
|
25
Maravai LifeSciences
MRVI
$1.11B
| $535K | 0.48% |
242,000
+38,000
| +19% | +$150K |
2022 Q4
9 quarters
|
|
Similar funds
ELM
FWS
CL
AFR
YAG
N
BCM
PHIMC
Alpine Peaks Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Alpine Peaks Capital held 25 positions worth $111M, down 8.9% from $122M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Alpine Peaks Capital's Q1 2025 filing shows 2 new, 9 increased and 14 reduced positions. Its largest new stake was Bio-Techne: 10,000 shares worth $586K. The largest sale was Rollins, an estimated $1.3M.
By sector, the portfolio is most concentrated in Industrials at 32% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.
- Alpine Peaks Capital's largest Q1 2025 buy was Bio-Techne: 10,000 shares worth $586K.
- Alpine Peaks Capital added most to US Physical Therapy in Q1 2025, an estimated $671K increase.
- Alpine Peaks Capital's biggest Q1 2025 reduction was Rollins, cutting an estimated $1.3M.
- Alpine Peaks Capital's ten largest holdings make up 60% of its $111M portfolio in Q1 2025.
- Alpine Peaks Capital opened 2 new positions and closed 0 in Q1 2025.
- Alpine Peaks Capital's portfolio value fell 8.9% quarter-over-quarter to $111M.
Based on Alpine Peaks Capital's 13F filing for Q1 2025, filed 15 May 2025.